Hadassah

Hadassah Pioneer Named Honorary President of International European Liver Congress

Tuesday, Mar 29 2016

Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit.

The European Association for the Study of the Liver (EASL) has named Prof. Daniel Shouval, founding head of the Hadassah Medical Center’s Liver Unit, “Honorary President” of its International Liver Congress™ 2016. The 2016 Conference will take place in Barcelona, April 13-17, with more than 10,000 researchers and physicians from five continents.

EASL's choice expresses recognition of Prof. Shouval's contribution to the understanding and treatment of liver disease in Israel and the world, particularly his work on developing a vaccine for hepatitis B. As a result of Prof. Shouval’s work, Israel was among the first countries to endorse universal vaccination for hepatitis B, a leading cause of liver cancer and liver failure.   Today, 189 of the 194 countries belonging to the World Health Organization recommend this vaccine.

Prof. Shouval was also involved in developing a vaccine for hepatitis A. Israel became the first country to institute universal vaccination for this disease, which was very common in the region. As a result, there was a 95 percent drop in its incidence among children and young adults. The vaccines he and his team created for hepatitis A and B have virtually wiped out these diseases.

In 1983, Prof. Shouval established the first liver unit in Israel at Hadassah, which he directed for almost 30 years until his retirement in 2010. He treated thousands of patients during his   long career at Hadassah, where he was responsible for many breakthroughs, mentored generations of outstanding liver experts, and published pivotal research papers. Today, he continues to teach medicine and to advise the World Health Organization and other health bodies in Europe, Asia, and Africa.

“As someone who has devoted his life to the study of the liver," said Prof. Shouval, “I am very moved at being chosen. More than that, the honor recognizes the work of the outstanding Hadassah liver team that provides hope to patients who had no hope. Furthermore, it recognizes the contribution of the Israeli medical establishment in general, and Hadassah in particular, in finding cures for diseases that threaten such a wide population."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Feb 22 2017

Fetal Surgery Lessens Crippling Spinal Damage

History was made at Hadassah Ein Kerem Hospital in Jerusalem on Thursday, February 9 when a team of Israeli surgeons successfully operated on a 5-month-old fetus using a new procedure that only three doctors in the world can perform, to alleviate some of the crippling effects of spina bifida.

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Hadassah Cardiologists Publicize Israel’s Dramatic Decrease in Cardiovascular Death

Prof. Emeritus Mervyn Gotsman and Prof. Israel Gotsman of Hadassah Hospital’s Heart Institute have coauthored an article which appeared in the European Heart Journal, highlighting the fact that “between 1998 and 2012, mortality from cardiovascular disease in Israel has fallen from 162 to 80 per 100,000 residents--a decrease of 50 percent.”

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Ambassadors of Health for Heart Smart Living: A Unique Hadassah Program

Knowing that the workplace is where people spend vast quantities of time, the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women launched a unique course to encourage heart healthy living—during the work day.

READ MORE ›
alt_text

Tuesday, Feb 21 2017

Hadassah Brings Health Empowerment to East Jerusalem

The increased incidence of diabetes in the Arab community, as well as the 60 percent higher rate of cardiovascular mortality among Arab women led the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women to develop a community-based program to cultivate leadership that embraces and advocates for healthy living which will reduce diabetes in this population.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More